Walters Group reports purchase of 4,335,000 Zentalis shares for $15.17 million
Reuters2026/08/19 22:12Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Walters Group reported a purchase of 4,335,000 Zentalis Pharmaceuticals common shares at USD 3.5 each.
- The stake rose to 17,844,973 shares following the transaction.
- Susan B. Walters, general partner, signed the filing alongside William T. Walters.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zentalis Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-091823), on August 19, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Benchmark sees over 500% upside in Strategy, reiterates $570 target on new capital framework
The Block•2026/08/19 23:09
Target Has Further Runway, Analysts Say -- Market Talk
Dow Jones•2026/08/19 23:06
Smart Sand CFO Lee E. Beckelman sells 50,000 shares worth $239,500
Reuters•2026/08/19 23:03
